slug: boltz provider: Boltz generated_by: planning/capability-mapping/scripts/classify_capabilities.py model: claude-opus-5 frame: - Pharmaceuticals & Life Sciences min_confidence: 0.7 capability_model: source: https://github.com/vincentmakes/turbo-ea-capabilities license: CC-BY-4.0 attribution: Turbo EA Capabilities by Vincent Verdet — Turbo EA, https://github.com/vincentmakes/turbo-ea-capabilities, CC BY 4.0 notice: NOTICE edge_count: 3 edges: - tag: Predictions spec_file: boltz-predictions-api-openapi.yml capability_id: BC-1500 capability_id_l1: BC-1500 capability_name: Drug Discovery Management confidence: 0.75 evidence: POST /compute/v1/predictions/structure-and-binding Start a structure & binding prediction; GET /compute/v1/predictions/adme reason: Biomolecular structure/binding-affinity and ADME prediction jobs are computational drug discovery work (target/lead assessment, ADME profiling). L1 Drug Discovery Management; sub-capability ambiguous between hit discovery, lead optimisation and pre-clinical ADME. - tag: Protein spec_file: boltz-protein-api-openapi.yml capability_id: BC-1500 capability_id_l1: BC-1500 capability_name: Drug Discovery Management confidence: 0.7 evidence: POST /compute/v1/protein/design proteinDesignStart Start a design job; GET /compute/v1/protein/library-screen List library screens reason: Generative protein design and library screening are hit discovery / lead optimisation activities in drug discovery. L1 confident; specific L2 ambiguous between BC-1500.20 and BC-1500.30. - tag: Small Molecule spec_file: boltz-small-molecule-api-openapi.yml capability_id: BC-1500 capability_id_l1: BC-1500 capability_name: Drug Discovery Management confidence: 0.7 evidence: POST /compute/v1/small-molecule/design smallMoleculeDesignStart Start a design job; POST /compute/v1/small-molecule/library-screen reason: Generative small-molecule design and virtual library screening map to drug discovery hit identification/lead optimisation; exact L2 ambiguous.